Lonza released FY17 numbers. Sales reached CHF5,105m (+23.5% and +10.4% without Capsugel), EBITDA CHF1,153m (+36% and +25% respectively), EBIT CHF723m (+48.8% and +49.8%), net profit CHF728m (+142%). Net debt reached CHF3,762m vs CHF1,584m a year before, of course impacted by the Capsugel acquisition. The dividend proposed for FY17 will be CHF2.75 (stable).
31 Jan 2018
A solid FY17 with sound prospects
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
A solid FY17 with sound prospects
Lonza Group AG (0QNO:LON) | 0 0 0.0% | Mkt Cap: 22,735m
- Published:
31 Jan 2018 -
Author:
Fabrice Farigoule -
Pages:
2
Lonza released FY17 numbers. Sales reached CHF5,105m (+23.5% and +10.4% without Capsugel), EBITDA CHF1,153m (+36% and +25% respectively), EBIT CHF723m (+48.8% and +49.8%), net profit CHF728m (+142%). Net debt reached CHF3,762m vs CHF1,584m a year before, of course impacted by the Capsugel acquisition. The dividend proposed for FY17 will be CHF2.75 (stable).